Sponsor pipeline

Ossium Health, Inc. clinical trial pipeline

Get alerts when Ossium Health, Inc.'s trials change

3 active trials 1 recruiting 8 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

Active trials by phase

Phase 1/2
1
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT05589896 A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased… Acute Leukemia Active, Not Recruiting 2026-09-10
Not applicable
NCT07710781 Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor… Hematologic Malignancy Not Yet Recruiting 2026-09-10
Not specified
NCT07145411 HPC Offered for PRESERVE Expansion Bone Marrow Transplant (BMT) Recruiting 2025-08-28

Disease areas by active trials

Acute Lymphoblastic Leukemia (ALL) (2) · Acute Myeloid Leukemia (AML) (2) · Chronic Lymphocytic Leukemia (CLL) (2) · Chronic Myeloid Leukemia (CML) (2) · Hodgkin Lymphoma (2) · Leukemia (2) · Myelodysplastic Syndromes (MDS) (2) · Non-Hodgkin Lymphoma (2)

Get alerts when Ossium Health, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free